Target intelligence / Profile preview

RNA, U6 small nuclear 82, pseudogene (RNU6-82P)

Target
RNU6-82P
Molecular classification
Other (pseudogene; derived from small nuclear RNA, snRNA), Non-coding RNA (as the original U6 is a small nuclear RNA; the pseudogene copy is non-coding)
01

Overview

The **RNU6-82P** locus encodes a **pseudogene derived from U6 small nuclear RNA (snRNA)**, which is itself a critical non-coding RNA involved in pre-mRNA splicing as a component of the spliceosome[1][2]. U6 snRNA’s true biological role is to participate in the formation of the catalytic core of the spliceosome complex, specifically facilitating excision of introns from fresh transcripts. However, **pseudogenes such as RNU6-82P do not produce functional RNAs or proteins and have no established biological activity**[5][3]. Their existence in the genome reflects historical gene duplication or retrotransposition—sometimes as chimeric products with other RNAs[5][3]. The major biological significance of these pseudogenes is to inform studies of genome evolution, retrotranspositional dynamics, and possibly transcriptome diversity, but they are *not targets for drug development nor do they play direct roles in disease, signaling, or cellular homeostasis*[5][3][1][2].

Other names
RNU6-82PRNU6-82U6 small nuclear RNA 82 pseudogene
02

Mechanism of action

None (pseudogene, not a drug target). For clarification, the functional form of U6 snRNA is not targeted directly by any approved therapies.

03

Biological functions

None (pseudogene; does not encode a functional product)The functional U6 snRNA is involved in pre-mRNA splicing as part of the major spliceosomal complex, but the pseudogene version has no known biological activity
04

Disease associations

None established for this pseudogene*Note*: The presence of snRNA pseudogenes, including U6 pseudogenes, can be used as markers of retrotransposition activity and evolutionary dynamics in the genome, but these are not disease roles in the therapeutic sense
05

Safety considerations

No safety concerns because pseudogenes are non-functional
06

Interacting drugs

None (pseudogene, non-functional, not a drug target)
07

Biomarkers

None known or used in clinical biomarker applications

Beyond the preview

Go deeper on RNA, U6 small nuclear 82, pseudogene (RNU6-82P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 82, pseudogene (RNU6-82P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call